394 related articles for article (PubMed ID: 29047459)
1. Protostemonine effectively attenuates lipopolysaccharide-induced acute lung injury in mice.
Wu YX; He HQ; Nie YJ; Ding YH; Sun L; Qian F
Acta Pharmacol Sin; 2018 Jan; 39(1):85-96. PubMed ID: 29047459
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
3. Dehydrocostus Lactone Suppresses LPS-induced Acute Lung Injury and Macrophage Activation through NF-κB Signaling Pathway Mediated by p38 MAPK and Akt.
Nie Y; Wang Z; Chai G; Xiong Y; Li B; Zhang H; Xin R; Qian X; Tang Z; Wu J; Zhao P
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999647
[TBL] [Abstract][Full Text] [Related]
4. Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE
Lee WS; Shin JS; Jang DS; Lee KT
Int Immunopharmacol; 2016 Nov; 40():146-155. PubMed ID: 27591413
[TBL] [Abstract][Full Text] [Related]
5. Protostemonine alleviates heat-killed methicillin-resistant Staphylococcus aureus-induced acute lung injury through MAPK and NF-κB signaling pathways.
Wu Y; Nie Y; Huang J; Qiu Y; Wan B; Liu G; Chen J; Chen D; Pang Q
Int Immunopharmacol; 2019 Dec; 77():105964. PubMed ID: 31669889
[TBL] [Abstract][Full Text] [Related]
6. Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury.
Lee JW; Park JW; Shin NR; Park SY; Kwon OK; Park HA; Lim Y; Ryu HW; Yuk HJ; Kim JH; Oh SR; Ahn KS
Int J Mol Med; 2016 Sep; 38(3):834-44. PubMed ID: 27431288
[TBL] [Abstract][Full Text] [Related]
7. Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis.
Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
Int Immunopharmacol; 2021 Jan; 90():107187. PubMed ID: 33249045
[TBL] [Abstract][Full Text] [Related]
8. O-Methylbulbocapnine and Dicentrine Suppress LPS-Induced Inflammatory Response by Blocking NF-κB and AP-1 Activation through Inhibiting MAPKs and Akt Signaling in RAW264.7 Macrophages.
Yodkeeree S; Ooppachai C; Pompimon W; Limtrakul Dejkriengkraikul P
Biol Pharm Bull; 2018; 41(8):1219-1227. PubMed ID: 30068871
[TBL] [Abstract][Full Text] [Related]
9. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages.
Li XN; Su J; Zhao L; Xiang JB; Wang W; Liu F; Li HY; Zhong JT; Bai X; Sun LK
Int Immunopharmacol; 2013 Nov; 17(3):785-92. PubMed ID: 24070708
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-Gallate (EGCG), an Active Compound of Green Tea Attenuates Acute Lung Injury Regulating Macrophage Polarization and Krüpple-Like-Factor 4 (KLF4) Expression.
Almatroodi SA; Almatroudi A; Alsahli MA; Aljasir MA; Syed MA; Rahmani AH
Molecules; 2020 Jun; 25(12):. PubMed ID: 32575718
[TBL] [Abstract][Full Text] [Related]
11. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of the six compounds isolated from Nauclea officinalis Pierrc ex Pitard, and molecular mechanism of strictosamide via suppressing the NF-κB and MAPK signaling pathway in LPS-induced RAW 264.7 macrophages.
Li D; Chen J; Ye J; Zhai X; Song J; Jiang C; Wang J; Zhang H; Jia X; Zhu F
J Ethnopharmacol; 2017 Jan; 196():66-74. PubMed ID: 27989509
[TBL] [Abstract][Full Text] [Related]
13. Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response.
Wang X; Yan J; Xu X; Duan C; Xie Z; Su Z; Ma H; Ma H; Wei X; Du X
Microb Pathog; 2018 May; 118():170-176. PubMed ID: 29571724
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-κB signaling pathways.
Yu X; Yu S; Chen L; Liu H; Zhang J; Ge H; Zhang Y; Yu B; Kou J
Biomed Pharmacother; 2016 Aug; 82():489-97. PubMed ID: 27470389
[TBL] [Abstract][Full Text] [Related]
15. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
[TBL] [Abstract][Full Text] [Related]
16. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling.
Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ
Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646
[TBL] [Abstract][Full Text] [Related]
17. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B.
Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL
J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940
[TBL] [Abstract][Full Text] [Related]
18. Scutellaria baicalensis Ameliorates Acute Lung Injury by Suppressing Inflammation In Vitro and In Vivo.
Chen JJ; Huang CC; Chang HY; Li PY; Liang YC; Deng JS; Huang SS; Huang GJ
Am J Chin Med; 2017; 45(1):137-157. PubMed ID: 28081626
[TBL] [Abstract][Full Text] [Related]
19. Lower Oligomeric Form of Surfactant Protein D in Murine Acute Lung Injury Induces M1 Subtype Macrophages Through Calreticulin/p38 MAPK Signaling Pathway.
Li D; Pan L; Zhang X; Jiang Z
Front Immunol; 2021; 12():687506. PubMed ID: 34484184
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression.
Ni YF; Kuai JK; Lu ZF; Yang GD; Fu HY; Wang J; Tian F; Yan XL; Zhao YC; Wang YJ; Jiang T
J Surg Res; 2011 Jan; 165(1):e29-35. PubMed ID: 21074783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
